drugset / Trial / NCT03984110

One Year Trial Evaluating Safety of Ozurdex With Eylea

NCT03984110

RandomizedSingle-groupOpen-labelTreatment

Summary

One Year Trial Evaluating Safety of Ozurdex With Eylea (COED)

Timeline

Start
2019-06-11
Primary completion
2022-10-27
Completion
2022-10-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Aflibercept Protein / enzyme biologic Intravitreal
Subject Dexamethasone Small molecule Intravitreal